UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?

Clinical microbiology and infection, 2013-10, Vol.19 (10), p.889-901

2013

Volltextzugriff (PDF)

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

Journal of internal medicine, 2001-01, Vol.249 (1), p.1-26

Van Soolingen, D.

2001

Volltextzugriff (PDF)

Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–2014

The international journal of tuberculosis and lung disease, 2019-11, Vol.23 (11), p.1162-1170

2019

Volltextzugriff (PDF)

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

Thorax, 2009-06, Vol.64 (6), p.502-506

2009

Volltextzugriff (PDF)

Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans

Clinical microbiology and infection, 2009-10, Vol.15 (10), p.888-893

2009

Volltextzugriff (PDF)

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge

The international journal of tuberculosis and lung disease, 2011-07, Vol.15 (7), p.990-992

2011

Volltextzugriff (PDF)

A New Evolutionary Scenario for the Mycobacterium tuberculosis Complex

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (6), p.3684-3689

2002

Volltextzugriff (PDF)

Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480

Antimicrobial Agents and Chemotherapy, 2011-03, Vol.55 (3), p.1287-1289

2011

Volltextzugriff (PDF)

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis

Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.3942-3947

2016

Volltextzugriff (PDF)

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Clinical microbiology and infection, 2013-05, Vol.19 (5), p.432-437

2013

Volltextzugriff (PDF)

Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex

The international journal of tuberculosis and lung disease, 2014-05, Vol.18 (5), p.594-600

2014

Volltextzugriff (PDF)

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0224422-e0224422

2023

Volltextzugriff (PDF)

Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?

The international journal of tuberculosis and lung disease, 2012-05, Vol.16 (5), p.639-644

2012

Volltextzugriff (PDF)

Rapid Identification of Mycobacteria by Raman Spectroscopy

Journal of Clinical Microbiology, 2008-03, Vol.46 (3), p.961-965

2008

Volltextzugriff (PDF)

Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure

The international journal of tuberculosis and lung disease, 2012-10, Vol.16 (10), p.1388-1392

2012

Volltextzugriff (PDF)

Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility

Journal of Clinical Microbiology, 1999-08, Vol.37 (8), p.2607-2618

1999

Volltextzugriff (PDF)

Corrigendum to ‘Should treatment of low-level rifampicin mono-resistant tuberculosis be different?’ [JCTUBE 23 (2021) 100241]

Journal of clinical tuberculosis and other mycobacterial diseases, 2021-08, Vol.24, p.100245-100245, Article 100245

2021

Volltextzugriff (PDF)

Role and value of whole genome sequencing in studying tuberculosis transmission

Clinical microbiology and infection, 2019-11, Vol.25 (11), p.1377-1382

2019

Volltextzugriff (PDF)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Journal of clinical tuberculosis and other mycobacterial diseases, 2021-05, Vol.23, p.100222-100222, Article 100222

2021

Volltextzugriff (PDF)

Should treatment of low-level mono-resistant tuberculosis be different?

Journal of clinical tuberculosis and other mycobacterial diseases, 2021-05, Vol.23, p.100241-100241, Article 100241

2021

Volltextzugriff (PDF)

‘Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.’† Do we have enough pieces to solve the pyrazinamide puzzle?

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1750-1754

2018

Volltextzugriff (PDF)

Emerging drugs and alternative possibilities in the treatment of tuberculosis

Expert opinion on emerging drugs, 2016-01, Vol.21 (1), p.103-116

2016

Volltextzugriff (PDF)

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria

Journal of antimicrobial chemotherapy, 2015-03, Vol.70 (3), p.811-817

2015

Volltextzugriff (PDF)

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(275)
Life Sciences & Biomedicine
(271)
Humans
(238)
Biological And Medical Sciences
(175)
Infectious Diseases
(175)
Microbiology
(154)
Mycobacterium Tuberculosis - Genetics
(144)
Mycobacterium Tuberculosis
(135)
Medical Sciences
(130)
Male
(112)
Tuberculosis
(109)
Female
(101)
Adult
(98)
Bacterial Diseases
(84)
Human Bacterial Diseases
(82)
Polymorphism, Restriction Fragment Length
(81)
Fundamental And Applied Biological Sciences. Psychology
(79)
Tuberculosis And Atypical Mycobacterial Infections
(79)
Middle Aged
(78)
Mycobacterium Tuberculosis - Isolation & Purification
(73)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–2014

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge

A New Evolutionary Scenario for the Mycobacterium tuberculosis Complex

Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area

Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?

Rapid Identification of Mycobacteria by Raman Spectroscopy

Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure

Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility

Corrigendum to ‘Should treatment of low-level rifampicin mono-resistant tuberculosis be different?’ [JCTUBE 23 (2021) 100241]

Role and value of whole genome sequencing in studying tuberculosis transmission

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Should treatment of low-level mono-resistant tuberculosis be different?

‘Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.’† Do we have enough pieces to solve the pyrazinamide puzzle?

Emerging drugs and alternative possibilities in the treatment of tuberculosis

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

Suchergebnisse filtern